W.H. Ludlam

2.3k citations

113 papers · 1.6k indexed · h-index 22

Impact in

Endocrinology, Diabetes and Metabolism top 1%
- Pituitary Gland Disorders and Treatments
- Growth Hormone and Insulin-like Growth Factors
- Adrenal Hormones and Disorders
Surgery top 10%
- Adrenal and Paraganglionic Tumors

Papers in

Endocrinology, Diabetes and Metabolism 98
- Pituitary Gland Disorders and Treatments 95
- Growth Hormone and Insulin-like Growth Factors 75
- Adrenal Hormones and Disorders 23
Pathology and Forensic Medicine 16
- Ophthalmology and Eye Disorders 16

Co-authors: Maureen P. Neary David M. Cook Michael S. Broder Eunice Chang John A. Kessler Maria Fleseriu Tanya Burton Asi Haviv
Journals: Pituitary (9 papers)Endocrine Practice (4 papers)Nature Communications (3 papers)The Journal of Clinical Endocrinology & Metabolism (3 papers)Neurosurgical FOCUS (2 papers)
Partner nations: United States Netherlands Germany

In The Last Decade

W.H. Ludlam

109 papers receiving 1.6k citations

Peers

Countries citing papers authored by W.H. Ludlam

Since Specialization

Citations

This map shows the geographic impact of W.H. Ludlam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.H. Ludlam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.H. Ludlam more than expected).

Fields of papers citing papers by W.H. Ludlam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.H. Ludlam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.H. Ludlam. The network helps show where W.H. Ludlam may publish in the future.

Co-authors

The 25 scholars most cited alongside W.H. Ludlam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with W.H. Ludlam Line = papers co-authored together W.H. Ludlam links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A neurodevelopmental disorder mutation locks G proteins in the transitory pre-activated state Nature Communications ·Medizinal-Abtheilung des Königlich Preussischen Kriegsministeriums, B. Krumm, Nicholas J. Kapolka, W.H. Ludlam, Meng Cui, G. Indra, Alex Mohandas, P. Liniewicz, Milenka Božanić, 박종철 정경화, Ning Ma, Xi‐Ping Huang, Jonathan F. Fay, Nagarajan Vaidehi, Alan V. Smrcka, Paul A. Slesinger, Diomedes E. Logothetis, Kirill A. Martemyanov, Bryan L. Roth, Henrik Dohlman	2024	5
2	Severity of GNAO1‐Related Disorder Correlates with Changes in G‐Protein Function Annals of Neurology ·明仁金, W.H. Ludlam, Liu Liang-bin, Y. H. Lee, Tinizaray Castillo, Jordi Muchart, Meruert Kylishbaevna Bissenova, Munseef Sadaqa, Juan Darío Ortigoza‐Escobar, Kirill A. Martemyanov, (unknown)	2023	19
3	The Molecular Chaperone CCT Sequesters Gelsolin and Protects it from Cleavage by Caspase-3 Journal of Molecular Biology ·Jorge Cuéllar, Itzhack Bayer, Joginder Redhu, G. Winnewisser, Jufeng Lu, W.H. Ludlam, Barry M. Willardson, José Valpuesta, Julie Grantham	2021	5
4	Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results Pituitary ·Jorge Lara-Arias, Lisa B. Nachtigall, Maria Fleseriu, Murray B. Gordon, Mark E. Molitch, L. Kennedy, Susan L. Samson, Yona Greenman, Nienke R. Biermasz, Marek Bolanowski, Asi Haviv, W.H. Ludlam, Gary Patou, Christian J. Strasburger	2021	15
5	An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies Pituitary ·Maria Fleseriu, Leon Fogelfeld, Murray B. Gordon, Diego Alonso Soares Dias, Ross D. Crosby, W.H. Ludlam, Asi Haviv, Susan D. Mathias	2020	23
6	Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice BMC Endocrine Disorders ·Eliza B. Geer, Diego Alonso Soares Dias, Daphne T. Adelman, W.H. Ludlam, Asi Haviv, Shuqian Liu, Susan D. Mathias, o Zid djh, Lizheng Shi	2020	31
7	Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider Pituitary ·Eliza B. Geer, Diego Alonso Soares Dias, Daphne T. Adelman, W.H. Ludlam, Asi Haviv, o Zid djh, Shuqian Liu, Susan D. Mathias, Lizheng Shi	2019	26
8	Molecular architecture of the Bardet–Biedl syndrome protein 2-7-9 subcomplex Journal of Biological Chemistry ·W.H. Ludlam, Bob Wielenga, Jorge Cuéllar, Jufeng Lu, Aman Makaju, James Moody, Sarah Franklin, José Valpuesta, Barry M. Willardson	2019	9
9	Budget impact of pasireotide LAR for the treatment of acromegaly, a rare endocrine disorder Journal of Medical Economics ·Luisa Modolo, Dave Nellesen, W.H. Ludlam, Maureen P. Neary	2015	8
10	Historical Response Rates Of Somatostatin Analogues In The Treatment Of Acromegaly: A Systematic Review Endocrine Practice ·Michael H. Shanik, Ali Reza Modanlo Joibary, W.H. Ludlam	2015	12
11	Incidence of Cushing’s syndrome and Cushing’s disease in commercially-insured patients <65 years old in the United States Pituitary ·Michael S. Broder, Maureen P. Neary, Eunice Chang, Dasha Cherepanov, W.H. Ludlam	2014	62
12	Burden of Illness, Annual Healthcare Utilization, and Costs Associated with Commercially Insured Patients with Cushing Disease in The United States Endocrine Practice ·Michael S. Broder, Maureen P. Neary, Eunice Chang, Dasha Cherepanov, W.H. Ludlam	2014	14
13	Budget impact of pasireotide for the treatment of Cushing’s disease, a rare endocrine disorder associated with considerable comorbidities Journal of Medical Economics ·Hong Truong, Dave Nellesen, W.H. Ludlam, Maureen P. Neary	2014	9
14	Annual Health Care Utilization And Costs In Cushing's Disease Patients In The United States Value in Health ·Michael S. Broder, Dito Wahyu Hardiyansyah, Eunice Chang, W.H. Ludlam, Dasha Cherepanov	2013	1
15	Safety review: Dose optimization of somatostatin analogs in patients with acromegaly and neuroendocrine tumors Advances in Therapy ·W.H. Ludlam, Lowell Anthony	2011	30
16	Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial The Journal of Clinical Endocrinology & Metabolism ·Marco Boscaro, W.H. Ludlam, Brew Atkinson, J. E. Glusman, Stephan Petersenn, Martín Reincke, Peter J. Snyder, Antoine Tabarin, Beverly M. K. Biller, James W. Findling, Шломо Мелмед, C. H. Darby, Ke Hu, Yan Lin, Pamela U. Freda, Ashley Grossman, L A Frohman, Jérôme Bertherat	2008	207
17	Second-line treatment for Cushing's disease when initial pituitary surgery is unsuccessful Current Opinion in Endocrinology Diabetes and Obesity ·Maria Fleseriu, D. Lynn Loriaux, W.H. Ludlam	2007	20
18	Cyclic Cushing syndrome: definitions and treatment implications Neurosurgical FOCUS ·Alma Rosyil Khilaq, Marc R. Mayberg, W.H. Ludlam	2007	21
19	LIF-and IL-1β-mediated increases in substance P receptor mRNA in axotomized, explanted or dissociated sympathetic ganglia Brain Research ·W.H. Ludlam, Karen J. Chandross, John A. Kessler	1995	26
20	Cytokine-induced programmed death of cultured sympathetic neurons Neuron ·John A. Kessler, W.H. Ludlam, Mona M. Freidin, David H. Hall, M. Dror Michaelson, David C. Spray, E T Carter, David K. Batter	1993	89

About W.H. Ludlam

W.H. Ludlam is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine, Surgery, Genetics and Structural Biology, having authored 113 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (95 papers), Growth Hormone and Insulin-like Growth Factors (75 papers), Adrenal and Paraganglionic Tumors (36 papers), Adrenal Hormones and Disorders (23 papers), Ophthalmology and Eye Disorders (16 papers), Myasthenia Gravis and Thymoma (7 papers), Neuroendocrine Tumor Research Advances (7 papers) and Glioma Diagnosis and Treatment (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Surgery (526 citations), Genetics (113 citations), Developmental Neuroscience (28 citations) and Epidemiology (229 citations). W.H. Ludlam has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Maureen P. Neary, David M. Cook, Michael S. Broder, Eunice Chang, John A. Kessler, Maria Fleseriu, Tanya Burton, Asi Haviv, Dasha Cherepanov and Elisabeth Le Nestour. Their work appears in journals such as Pituitary, Endocrine Practice, Nature Communications, The Journal of Clinical Endocrinology & Metabolism and Neurosurgical FOCUS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact